Clinical Trial Update: Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer [NA]

View source ↗

Summary

A completed clinical trial reports that bicalutamide monotherapy provides significant quality-of-life benefits for men with advanced prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• bicalutamide (bicalutamide)

Snippet

Sponsor: Wirral University Teaching Hospital NHS Trust | Conditions: Prostatic Neoplasms | NA | Status: COMPLETED